“Acucela Inc. (TOKYO: 4589), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, today announced that its 2015 Annual Meeting of Shareholders will be held
“Acucela Inc. (TOKYO: 4589), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, today announced that its 2015 Annual Meeting of Shareholders will be held
frothmouth のブックマーク 2015/03/05 01:29
このブックマークにはスターがありません。
最初のスターをつけてみよう!
Acucela to Hold 2015 Annual Meeting of Shareholders on June 8, 2015
www.businesswire.com2015/03/05
1 人がブックマーク・1 件のコメント
\ コメントが サクサク読める アプリです /